Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
| Catalog No. | Product Name | Size | List Price (US$) | Quantity |
|---|
The manufacturing conditions of Vectibix biosimilar from the CHO stable cell line need to be optimized by clients.
The cheapest research grade panitumumab biosimilar protein (1 mg for >$30) is also available.
Price/availability/specifications subject to change without notice. Unless otherwise indicated, our catalog and customized products are for research use only and not intended for human or animal diagnostic or therapeutic use.
Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
Panitumumab (ABX-EGF, trade name Vectibix, Amgen), a fully anti-EGFR (epidermal growth factor receptor, EGF receptor, ErbB-1 and HER1 in humans) human monoclonal antibody, is used for the treatment of refractory EGFR-expressing metastatic colorectal cancer in patients with non-mutated (wild-type) KRAS".
C012: Vectibix Biosimilar Stable Cell Line (CHO)
The yield of Vectibix biosimilar from the CHO stable cell line was above 2.0 g/L in a 3 liter manufacturing.
The Vectibix biosimilar stable cell line alone can be transferred alone or together with the technology of process development and/or antibody purification.
Syd Labs also provides the following anti-ErbB/HER antibody biosimilar stable cell lines:
Erbitux Biosimilar Stable Cell Line (HER1, ErbB-1, EGFR)
Herceptin Biosimilar Stable Cell Line (HER2, ErbB-2, c-neu)
Perjeta / Omnitarg Biosimilar Stable Cell Line (HER2, ErbB-2, c-neu)
Copyright © 2009-2022 sydlabs.com. All rights reserved.
Use of this website means that you have read, understood, and accepted the Syd Labs Privacy Policy and Terms & Conditions.